OTCMKTS:PARNF

Parnell Pharmaceuticals (PARNF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
75 shs
Market Capitalization
$10,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PARNF stock logo

About Parnell Pharmaceuticals Stock (OTCMKTS:PARNF)

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

PARNF Stock News Headlines

Trump just won 2024
President Trump signed an executive order that ensures he’ll be remembered as one of America’s greatest Presidents. It was an Executive Order that received almost no media attention…
Parnell Pharmaceuticals Holdings Ltd (PARNF)
The best Netflix original movies right now
😱 This phenomenon is smashing regular market gains
Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.
PARNF - Parnell Pharmaceuticals Holdings Ltd
See More Headlines
Receive PARNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Parnell Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PARNF
Previous Symbol
NASDAQ:PARN
CIK
N/A
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$25.80 million

Miscellaneous

Free Float
N/A
Market Cap
$10,000.00
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Alan Richard Bell (Age 68)
    Executive Chairman
  • Mr. Brad R. McCarthy CPA (Age 48)
    CEO, CFO, Chief Accounting Officer, Company Secretary & Executive Director

PARNF Stock Analysis - Frequently Asked Questions

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PARNF) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners